πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 61 of 78

  1. US 7335356

    Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7335477

    Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7335749

    Tumor suppressor gene, p47Ing3

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7332170

    Classical swine fever virus virulence determinant and a novel classical swine fever vaccine

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7332590

    Molecular characteristics of non-small cell lung cancer

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7332645

    IL-21 as a regulator of immunoglobin production

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7332172

    Transformed bacteria producing CS6 antigens as vaccines

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7330748

    Method for determining in vivo concentration of a metabolite

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7329502

    ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7320991

    Analogs of thalidomide as potential angiogenesis inhibitors

    Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7319091

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7317086

    Basal cell carcinoma tumor suppressor protein

    Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7314625

    Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequences

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7314632

    Pseudomonas exotoxin A-like chimeric immunogens

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7314631

    Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7312228

    Cytotoxic indeno and isoindoloisoquinolones

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7311916

    Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7306806

    Recombinant P. falciparum merozoite protein-142 vaccine

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7306808

    Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7303754

    MVA expressing modified HIV envelope, gag, and pol genes

    Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7303751

    Anti-plasmodium compositions and methods of use

    Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7304127

    Polypeptides that bind HIV gp120 and related nucleic acids, antibodies, compositions, and methods of use

    Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7300940

    Integrin Ξ±-v Ξ²-3 antagonists for use in imaging and therapy

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7288266

    Liposome complexes for increased systemic delivery

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7288254

    Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7282205

    Anti-hepatitis A virus antibodies

    Expires Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7282206

    Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains

    Expires Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7279163

    Water-in-oil emulsion vaccines

    Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7279320

    Curlicue vaccine strain of Bacillus anthracis

    Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7279294

    Tumor markers in ovarian cancer

    Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7276227

    Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity

    Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7271150

    Modified growth hormone

    Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7268118

    Thymosin Ξ²4 compositions

    Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7267941

    Cyanovirin variant-polymer conjugates

    Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7267823

    Ebola peptides and immunogenic compositions containing same

    Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7264947

    Activity dependent neurotrophic factor III (ADNF III)

    Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7265215

    DNA or RNA encoding a recombinant dengue envelope protein

    Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7261896

    Methods for preventing strokes by inducing tolerance to e-selectin

    Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7261900

    Recombinant modified Bacillus anthracis protective antigen for use in vaccines

    Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7262027

    Polypeptide and DNA immunization against Coccidioides spp. infections

    Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7259167

    Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof

    Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7258863

    Heterologous protection induced by immunization with invaplex vaccine

    Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7258859

    Method for the treatment of multiple sclerosis

    Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7259142

    Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use

    Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7256260

    Human p53 mutations and a genetic system in yeast for functional identification of human p53 mutations

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7256256

    CDK4 binding peptide

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7256281

    Recombinant P. falciparum merozoite protein-142 vaccine

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7256004

    Variants of humanized anti-carcinoma monoclonal antibody CC49

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.